Evidence map›Paper›PMID 35501775›Full record

ReviewBMC ophthalmology2022

Intraocular myofibroblastoma tumour of the ciliary body: a case report and literature review.

He Yu, Caixin Zhang, Nianting Tong, Xiu Wang, Liangyu Wang, Huimin Gong, Xin Liu, Zhanyu Zhou

Abstract readCase ReportsReview
In one paragraph

Review in BMC ophthalmology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

He YuDepartment of Ophthalmology, Qingdao Municipal Hospital, 5 Middle Donghai Road, Shinan District, Qingdao, Shandong, China.
Caixin ZhangDepartment of Pathology, Qingdao Municipal Hospital, No.5 Donghai Middle Road, Shinan District, Qingdao, Shandong, China.
Nianting TongDepartment of Ophthalmology, Qingdao Municipal Hospital, 5 Middle Donghai Road, Shinan District, Qingdao, Shandong, China.
Xiu WangDepartment of Ophthalmology, Qingdao Municipal Hospital, 5 Middle Donghai Road, Shinan District, Qingdao, Shandong, China.
Liangyu WangDepartment of Ophthalmology, Qingdao Municipal Hospital, 5 Middle Donghai Road, Shinan District, Qingdao, Shandong, China.
Huimin GongDepartment of Ophthalmology, Qingdao Municipal Hospital, 5 Middle Donghai Road, Shinan District, Qingdao, Shandong, China.
Xin LiuDepartment of Ophthalmology, Dalian No,3 People's Hospital, No. 40 Qianshan Road,Ganjingzi District, Dalian, Liaoning, China.
Zhanyu ZhouDepartment of Ophthalmology, Qingdao Municipal Hospital, 5 Middle Donghai Road, Shinan District, Qingdao, Shandong, China. zhouzyqdsl@163.com.ORCID http://orcid.org/0000-0003-4101-8365

Funding

national natural science foundation of china 81801381
6 · The paper itself

Abstract

backgroundInflammatory Myofibroblastoma Tumors (IMTs) are extremely tumour rare in the intraocular. CASE PRESENTATION: A ciliary body tumor was found under slit lamp biomicroscopy in a 55-year-old male first diagnosed with cataract. Then this patient underwent trans-sclera resection via partial lamellar sclerouvectomy and par plans vitrectomy to remove the mass. Hematoxylin and eosin (HE) staining and immunohistochemistry findings showed that the characteristics of the tumor were consistent with IMT.

conclusionsWe reported a rare case of intraocular IMT, which is confirmed by H&E staining, and IHC positive staining for Vimentin, Desmin and ALK, while negative staining for SMA, S-100, ki-67, CK, CD68, and calponin.

Indexed as

Neoplasms, Muscle TissueUveal NeoplasmsCiliary BodyHumansImmunohistochemistryMaleMiddle Agedciliary bodyimmunohistochemistryInflammatory myofibroblastoma tumor

Identifiers

PMID35501775
PMCPMC9063157

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.